VIMOVO
Country: Ísrael
Tungumál: enska
Heimild: Ministry of Health
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG
Fáanlegur frá:
ASTRA ZENECA ISRAEL LTD
ATC númer:
G02CC02
Lyfjaform:
TABLETS MODIFIED RELEASE
Stjórnsýsluleið:
PER OS
Framleitt af:
ASTRA ZENECA AB., SWEDEN
Meðferðarhópur:
NAPROXEN
Ábendingar:
Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.
Leyfisdagur:
2011-12-01
